Carasent

Delisting Announcement • Nov 8, 2024

Carasent ASA - Carasent AB (publ) has been approved for listing on Nasdaq Stockholm

Carasent ASA - Carasent AB (publ) has been approved for listing on Nasdaq Stockholm

Nasdaq Stockholm has today notified Carasent AB (publ) ("Carasent" or the

"Company") of its assessment that the Company fulfills Nasdaq Stockholm's

listing requirements. Nasdaq Stockholm will approve an application for

admission to trading of the Company's shares, subject to the fulfilment of

certain customary conditions, including the approval and registration of a

prospectus by the Swedish Financial Supervisory Authority.

As announced on 30 August 2024 the Carasent ASA board of directors resolved on

a cross-border merger plan to effect the planned relisting of its shares on

Nasdaq Stockholm. Carasent ASA's Extraordinary General Meeting approved the

merger plan on 4 October 2024 as previously announced. The cross-border merger

is expected to be completed on 4 December 2024, upon which shareholders will

have their shares in Carasent ASA one for one exchanged with shares in

Carasent.

The last day of trading on Oslo Børs is expected to be 4 December 2024 and the

first day of trading on Nasdaq Stockholm is expected to be 9 December 2024.

The dates can be changed and if so, this will be announced in a stock exchange

announcement.

Shareholders in Carasent ASA are recommended to contact their bank to make

sure that their accounts can hold Swedish listed shares ahead of the

relisting. For further information please see https://carasent.com/investors

and https://www.nordnet.no/no/kampanjer/carasent.

For further information, please contact

Daniel Öhman, CEO Tel: +46 70-855 37 07, or

Svein Martin Bjørnstad, CFO Tel: +47 979 69 493